Valeant Pharmaceuticals International Inc (NYSE:VRX)

18.68
Delayed Data
As of Feb 23
 +0.41 / +2.24%
Today’s Change
8.31
Today|||52-Week Range
24.43
-10.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash542.0M1.2B2.0B1.9B
 
 
 
 
 
Short Term Investment Cash-116.9M668.0M803.3M19.6M
 
 
 
 
 
Cash & Short Term Investments543.0M1.2B2.0B1.9B
 
 
 
 
 
 
ReceivablesReceivables2.5B2.1B2.1B2.2B
 
 
 
 
 
 
InventoriesInventories1.1B1.1B1.1B1.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses8.0M------
 
 
Other Current Assets948.0M915.0M787.0M752.0M
 
 
 
 
 
Current Assets5.1B5.3B6.0B5.9B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.5B------
 
 
Depreciation-1.2B------
 
 
Intangible Assets34.7B33.9B33.4B31.6B
 
 
 
 
 
Other Assets37.0B35.5B34.2B32.5B
 
 
 
 
 
Total Assets43.5B42.3B41.7B40.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable324.0M368.0M371.0M407.0M
 
 
 
 
 
Short Term Debt7.0M353.0M813.0M925.0M
 
 
 
 
 
Accrued Expenses12.0M19.0M12.0M--
 
 
 
 
Other Current Liabilities2.9B3.1B2.9B3.0B
 
 
 
 
 
Other Liabilities3.6B4.2B4.5B4.7B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt29.8B28.2B27.6B26.2B
 
 
 
 
 
Deferred Taxes-5.3B-4.3B-4.1B-2.1B
 
 
 
 
 
Other Liabilities1.0B954.0M859.0M908.0M
 
 
 
 
 
Total Liabilities40.3B38.3B37.7B34.6B
 
 
 
 
 
 
EquityMinority Interest-3.0M-1.0M-1.0M-1.0M
 
 
 
 
 
Preferred Stock0.000.00------
Common Equity3.2B3.9B3.9B5.3B
 
 
 
 
 
Total Shareholder Equity3.2B3.9B3.9B5.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding347.8M347.9M348.5M348.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.